Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods

Open Access
Publisher Website
Google Scholar
Abstract
Increased attention to human papillomavirus (HPV)‐associated cancers in light of the recent release of an HPV vaccine, as well as increased availability of cancer registry data that now include reporting from a large proportion of the US population, prompted the current assessment of HPV‐associated cancers. This article describes methods used to assess the burden of HPV‐associated cervical, vulvar, vaginal, penile, anal, and oral cavity/oropharyngeal cancers in the United States during 1998 through 2003 using cancer registry data, and it provides a brief overview of the epidemiology of these cancers. Cancer 2008;113(10 suppl):2841–54. Published 2008 by the American Cancer Society.